EVKn.DE
Latest Trade
24.00EURChange
-0.16(-0.66%)Volume
377,170Today's Range
-
24.1952 Week Range
-
27.59As of on the XETRA ∙ Minimum 15 minute delay
Previous Close | 24.16 |
|---|---|
Open | 24.18 |
Volume | 377,170 |
3M AVG Volume | 20.89 |
Today's High | 24.19 |
Today's Low | 23.90 |
52 Week High | 27.59 |
52 Week Low | 15.13 |
Shares Out (MIL) | 466.00 |
Market Cap (MIL) | 11,184.00 |
Forward P/E | 17.09 |
Dividend (Yield %) | 4.79 |
Evonik Sees Q3 Resilience In Stable Businesses, Steady Recovery In More Impacted Ones - Conf Call
Evonik Q2 Adj. EBITDA Down 19% YoY At EUR 456 Mln
Siemens: Siemens Energy Builds Power Plant For Evonik In Germany
Evonik Industries AG (Evonik) is a Germany-based specialty chemicals company that operates in four segments: The Nutrition and Care segment produces specialty chemicals, mainly for use in consumer goods for daily needs and food, as well as nutrition for animal food and healthcare products; the Resource Efficiency segment offers material solutions for environment-friendly and energy-efficient products used in the automotive, adhesives and construction industries, among others; the Performance Materials segment produces polymer materials and their intermediates, mainly for the rubber, plastics and agriculture sectors, and the Services segment comprises site management, utilities and waste management, as well as technical, process technology, engineering and logistics services for the chemicals segments and external customers at the Company's sites. Its majority shareholder is RAG Stiftung.
Industry
Chemical Manufacturing
Executive Leadership
Bernd Tonjes
Independent Chairman of the Supervisory Board
Christian Kullmann
Chairman of the Executive Board
Edeltraud Glaenzer
Deputy Chairman of the Supervisory Board
Harald Schwager
Deputy Chairman of the Executive Board
Ute Wolf
Chief Financial Officer, Member of the Executive Board
Price To Earnings (TTM) | 18.21 |
|---|---|
Price To Sales (TTM) | 0.89 |
Price To Book (MRQ) | 1.27 |
Price To Cash Flow (TTM) | 7.48 |
Total Debt To Equity (MRQ) | 54.18 |
LT Debt To Equity (MRQ) | 41.24 |
Return on Investment (TTM) | 3.61 |
Return on Equity (TTM) | 2.97 |
German chemicals group Evonik Industries <EVKn.DE> reported on Tuesday higher-than-expected quarterly adjusted core profit, saying portfolio changes and its efficiency programs partially offset the effects of the coronavirus pandemic.
German chemicals group Evonik Industries reported on Tuesday higher-than-expected quarterly adjusted core profit, saying portfolio changes and its efficiency programs partially offset the effects of the coronavirus pandemic.
German chemicals group Evonik Industries <EVKn.DE> lowered on Thursday its full-year outlook, citing challenges in logistics and production from the coronavirus pandemic after reporting smaller-than-expected drop in first quarter core profit.
German chemicals group Evonik Industries lowered on Thursday its full-year outlook for 2020, citing challenges in logistics and production amid the coronavirus pandemic.
* ACHIEVES MAJOR BIOTECH BREAKTHROUGH WITH A NEW ANIMAL-FREE AND FERMENTATION-BASED COLLAGEN PLATFORM Source text for Eikon: Further company coverage: (Gdansk Newsroom)
German chemicals group Evonik Industries forecast stable 2020 sales on Wednesday, with its specialty chemicals sales expected to grow but softer global economy weighing on its more commoditized businesses.
German chemicals group Evonik Industries reported on Wednesday higher-than-expected quarterly adjusted core profit and forecast steady sales in 2020, with growth at its specialty business offset by softer sales of more commoditized chemicals.
* BVB - EVONIK INDUSTRIES AG NOW HOLDS 9.83% OF BVB SHARES AS OF FEB. 14, 2020 Source text for Eikon: Further company coverage: (Gdansk Newsroom)
A federal judge has ruled that Germany's Evonik Industries AG's <EVKn.DE> proposed purchase of rival U.S. hydrogen peroxide maker PeroxyChem Holding Company is legal under antitrust law.
A federal judge has ruled that Germany's Evonik Industries AG's proposed purchase of rival U.S. hydrogen peroxide maker PeroxyChem Holding Company is legal under antitrust law.
* FIRMENICH - ACQUIRES EVONIK'S CO2 EXTRACTION TECHNOLOGY DIVISION, STRENGTHENING ITS LEADERSHIP ROLE IN NATURAL FRAGRANCE AND FLAVORING
Evonik Industries met third-quarter profit expectations and said it remains on track for the year despite a slowing German chemicals sector, sending its shares 4% higher on Tuesday.
German chemicals group Evonik Industries on Tuesday reported a 6% drop in its third-quarter adjusted core profit, citing global economic slowdown.
The U.S. Federal Trade Commission said on Friday it was suing to stop Evonik Industries AG's <EVKn.DE> proposed purchase of rival hydrogen peroxide maker PeroxyChem Holding Company, citing concerns that the deal would lead to higher prices.
The Federal Trade Commission said on Friday that it was suing to stop Evonik Industries AG's purchase of rival hydrogen peroxide maker PeroxyChem Holding Company. (Reporting by Diane Bartz, editing by G Crosse)
* In drive to overcome weak stock-market valuation (Adds details on unit to be divested, 2018 guidance)
The chairman of Evonik's supervisory board, Werner Mueller, will step down for health reasons, Evonik's biggest shareholder said on Wednesday.
Evonik <EVKn.DE> has become the latest German chemical maker seeking to convert excess renewable power into chemical building blocks that would normally require oil, harnessing erratic flows of wind and solar power in the country.
* EVONIK AND FUFENG GROUP ENTER STRATEGIC PARTNERSHIP FOR THE PRODUCTION OF THREAMINO®
* SAYS TO ACQUIRE HIGH-CONCENTRATES ADDITIVE COMPOUNDING BUSINESS FROM 3M http://bit.ly/2nazicJ Further company coverage:
Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.